Landmark Global Study Finds Distinct 'Metabo-Psychiatric' Genetic Profiles for Binge Eating and Anorexia Nervosa
3 sources · 17d ago
White House Order Removes Key Vaccines from Universal Childhood Schedule, Drawing Public Health Alarm
7 sources · 20d ago
Single-Dose Gene Therapy Slashes LDL Cholesterol by 62% in Landmark Trial
6 sources · 21d ago
More in Public Health
CDC Warns Multi-Drug Resistant Candida auris Superbug Cases Exceed 3,400 in 27 States
3 sources · 24d ago
FDA Approves First-in-Class Cereblon E3 Ligase Modulator for Multiple Myeloma
8 sources · 12d ago
WHO Warns DRC Ebola Outbreak Now Outpacing Global Response as Deaths Top 2,000
6 sources · 27d ago
Landmark Study Dispels Fears: Acetaminophen and Ibuprofen Equally Safe for Infants
6 sources · 29d ago
Multi-State Salmonella Outbreak Linked to Jalapeño Peppers Sickens 345, Prompts Recall
4 sources · 31d ago
Blindspot
Important stories the mainstream barely covered
High-impact news with only 1–3 outlets covering it. These stories matter — they just didn't make the radar.
Former Fauci Aide David Morens Pleads Guilty to Concealing COVID-19 Origin Records
Dr. David Morens, a former senior adviser at the National Institutes of Health, pleaded guilty to a federal conspiracy charge for using personal email to hide communications about COVID-19 research grants from public records laws.
FDA Grants Accelerated Approval to First Systemic Oncolytic Viral Therapy for Advanced Melanoma
The FDA has greenlit a new intravenous viral therapy that hunts and destroys metastatic melanoma cells, offering a novel option for patients who have exhausted standard immunotherapies.
FDA Schedules Advisory Committee Review for Galleri Multi-Cancer Early Detection Blood Test
The FDA will convene an expert panel in September to review GRAIL's Galleri blood test, a pivotal step that could lead to the first regulatory approval for a multi-cancer early detection screening tool.








